Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts

Por um escritor misterioso
Last updated 12 abril 2025
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Background/Purpose: According to international recommendations, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is the preferred score for assessing disease activity in axial spondyloarthritis (axSpA) [1]. However, routine determination of C-reactive protein (CRP) to calculate ASDAS values takes hours to days. This limits the use of ASDAS in clinical routine and clinical trials and hinders the […]
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) Performance of the Ankylosing Spondylitis Disease Activity
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Gerd BURMESTER, Professor
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
POS0241 VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
J. Brandt-Juergens's research works
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) Performance of the Ankylosing Spondylitis Disease Activity
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Which Disease Activity Outcome Measure Discriminates Best in Axial
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
J. Brandt-Juergens's research works
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) Performance of the Ankylosing Spondylitis Disease Activity
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
ASDAS states in patients stratified by baseline MRI/CRP status
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
J. Brandt-Juergens's research works
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical

© 2014-2025 trend-media.tv. All rights reserved.